(redirected from allotransplants)
Also found in: Dictionary.
Related to allotransplants: allogeneic, Allografts


tr.v. allotrans·planted, allotrans·planting, allotrans·plants
To transfer (an organ or body tissue) between two genetically different individuals belonging to the same species.
An organ or tissue transferred between genetically different individuals of the same species.

al′lo·trans′plan·ta′tion n.
The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.


(al″ō-trans″plan″tā′shŏn) [ allo- + transplantation]
Grafting or transplantation of tissue from one individual into another of the same species.
allotransplant (-trans′plant″)
Medical Dictionary, © 2009 Farlex and Partners
References in periodicals archive ?
Their main task is to provide sufficient quantities of clinically safe bone and ligamentous allotransplants having adequate biological and biomechanical qualities essential for their clinical implementation [28].
By establishing the bone bank, bone and ligamentous allotransplants, both from cadaver donors (within transplant program) and alive donors (head of the femur after arthroplasty procedures to hip joint), have been applied for the last 8 years.
In addition to PERV, porcine cytomegalovirus, herpesvirus, and hepatitis E virus also should be controlled since these viruses are common in immune-suppressed recipients of allotransplants (Mueller et al., 2004; Kamar et al., 2008).
Interestingly, chapters 7, 8, and 11 deal with artificial organs and the potential of cyborg creation, composite tissue allotransplants (for example, face and hand transplants), and demonic exorcism as a treatment option for psychiatrists.
Silber said that he believes the appeal of this more patient-friendly ovarian transplantation could be wide reaching, extending beyond autotransplants for chemotherapy patients and even beyond allotransplants for patients with premature ovarian failure.
Unlike allotransplants (human organ transplants), individuals that undergo xenotransplants would be required to consent to lifelong xenozoonosis surveillance.
Additional kidney allotransplants to the groins of patients ended in only short-term success until a tiny ray of Mendelian science entered the picture.
From these findings, sHLA-G dimers might be useful as a potential marker to control rejection and the inflammatory status of human kidney allotransplants.
Allotransplants were performed between semiallogenic LBN donors and euthymic and thymectomized Lewis rat recipients without maintenance therapy.
Furthermore, a pilot study on human islet allotransplant patients also showed promising results.